Netherlands Home Infusion Therapy Market Size & Outlook

The home infusion therapy market in the Netherlands is expected to reach a projected revenue of US$ 606.7 million by 2030. A compound annual growth rate of 9.2% is expected of the Netherlands home infusion therapy market from 2024 to 2030.
Revenue, 2023 (US$M)
$328.6
Forecast, 2030 (US$M)
$606.7
CAGR, 2024 - 2030
9.2%
Report Coverage
Netherlands

Netherlands home infusion therapy market, 2018-2030 (US$M)

Netherlands

Related Markets

Netherlands home infusion therapy market highlights

  • The Netherlands home infusion therapy market generated a revenue of USD 328.6 million in 2023 and is expected to reach USD 606.7 million by 2030.
  • The Netherlands market is expected to grow at a CAGR of 9.2% from 2024 to 2030.
  • In terms of segment, anti-infective was the largest revenue generating application in 2023.
  • Chemotherapy is the most lucrative application segment registering the fastest growth during the forecast period.


Home infusion therapy market data book summary

Market revenue in 2023USD 328.6 million
Market revenue in 2030USD 606.7 million
Growth rate9.2% (CAGR from 2023 to 2030)
Largest segmentAnti-infective
Fastest growing segmentChemotherapy
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAnti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals
Key market players worldwideCVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics


Other key industry trends

  • In terms of revenue, Netherlands accounted for 0.9% of the global home infusion therapy market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany home infusion therapy market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 2,883.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Home Infusion Therapy Market Companies

Name Profile # Employees HQ Website

Netherlands home infusion therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.


Anti-infective was the largest segment with a revenue share of 24.38% in 2023. Horizon Databook has segmented the Netherlands home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.


According to National Institute for Public Health and the Environment, nearly 1 in every 5 people in the Netherlands will have more than three chronic diseases by 2040. Moreover, by 2040, mental disorders, cardiovascular diseases, and cancer are expected to be the most commonly diagnosed disease groups, whereas arthrosis, neck & back pain, and diabetes are expected to rapidly increase during the next few years. 

Growing prevalence of these diseases is anticipated to fuel market growth in the country. According to the study published in the PLOS ONE, it has been estimated that administration of home treatment in the country costs around USD 133 per hour , whereas the per day cost of inpatient care of a physically disabled person is about USD 228 , which acts as a costeffective alternative for chronic care patients. 

Furthermore, home care costs are shared by municipalities, insurers, & the national government and is financed via the Health Insurance Act. In addition, hospice care is covered under the Long-term Care Act. The inclusion of home care in publicly financed patient care is anticipated to reduce the financial burden on patients and significantly increase the adoption of home infusion therapies in the country.

Reasons to subscribe to Netherlands home infusion therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Netherlands home infusion therapy market databook

  • Our clientele includes a mix of home infusion therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Netherlands home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Netherlands home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Netherlands home infusion therapy market size, by application, 2018-2030 (US$M)

Netherlands Home Infusion Therapy Market Outlook Share, 2023 & 2030 (US$M)

Netherlands home infusion therapy market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more